Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Cymbalta ® (duloxetine)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
Cymbalta (duloxetine): List of excipients
Cymbalta capsules contain additional ingredients.
Capsule Content
Hypromellose
Hypromellose acetate succinate
Sucrose
Sugar spheres
Talc
Titanium dioxide (E171)
Triethyl citrate
Capsule Shell
Cymbalta 30 mg: Gelatin, sodium lauryl sulfate, titanium dioxide (E171), indigo carmine (E132), edible green ink. Edible green ink contains: black iron oxide-synthetic (E172), yellow iron oxide-synthetic (E172), propylene glycol, shellac.
Cymbalta 60 mg: Gelatin, sodium lauryl sulfate, titanium dioxide (E171), indigo carmine (E132), yellow iron oxide (E172), edible white ink. Edible white ink contains: titanium dioxide (E171), propylene glycol, shellac, povidone.
Reference
Cymbalta [Summary of Product Characteristics]. Utrecht, The Netherlands: Eli Lilly Nederland B.V.
Date of Last Review: 14 December 2021